{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:11:50Z","timestamp":1782943910151,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Pfizer Quality Improvement grant","award":["76405727"],"award-info":[{"award-number":["76405727"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273526"],"award-info":[{"award-number":["82273526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-JC-QN-0924"],"award-info":[{"award-number":["2023-JC-QN-0924"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017591","name":"Key Industry Innovation Chain of Shaanxi","doi-asserted-by":"publisher","award":["2024SF-ZDCY L-01-14"],"award-info":[{"award-number":["2024SF-ZDCY L-01-14"]}],"id":[{"id":"10.13039\/501100017591","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government","award":["xtr062023002"],"award-info":[{"award-number":["xtr062023002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13555-025-01508-w","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:47:23Z","timestamp":1754394443000},"page":"2897-2910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treat-to-Target in Clinical Practice: Evaluating Real-World Achievement Rates Against Consensus Guidelines for Atopic Dermatitis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-5695","authenticated-orcid":false,"given":"Zhao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"2","key":"1508_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jaad.2022.06.008","volume":"88","author":"GY Duan","year":"2023","unstructured":"Duan GY, Silverberg JI. Sleep impairment in patients with chronic inflammatory skin diseases: a review of mechanisms and management. J Am Acad Dermatol. 2023;88(2):421\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"1508_CR2","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.3390\/jcm12165370","volume":"12","author":"C Gu","year":"2023","unstructured":"Gu C, Yao X, Li W. Burden of disease; the current status of the diagnosis and management of atopic dermatitis in China. J Clin Med. 2023;12(16):5370.","journal-title":"J Clin Med"},{"issue":"10478","key":"1508_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","volume":"405","author":"E Guttman-Yassky","year":"2025","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405(10478):583\u201396.","journal-title":"Lancet"},{"issue":"2","key":"1508_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1089\/derm.2024.0197","volume":"36","author":"J Horeczko","year":"2025","unstructured":"Horeczko J, Alexis A, Silverberg JI. The heterogeneous clinical manifestations of atopic dermatitis across diverse patient populations. Dermatitis. 2025;36(2):118\u201324.","journal-title":"Dermatitis"},{"key":"1508_CR5","doi-asserted-by":"crossref","unstructured":"Fyhrquist N, Yang Y, Karisola P, Alenius H. Endotypes of atopic dermatitis. J Allergy Clin Immunol. 2025;156(1):24\u201340.e4.","DOI":"10.1016\/j.jaci.2025.02.029"},{"key":"1508_CR6","doi-asserted-by":"publisher","unstructured":"Yao X, Li W. Pathogenesis and treatment of atopic dermatitis: lessons from China. Clin Exp Allergy. 2025. https:\/\/doi.org\/10.1111\/cea.14631.","DOI":"10.1111\/cea.14631"},{"issue":"3","key":"1508_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41584-021-00739-3","volume":"18","author":"AR Parra Sanchez","year":"2022","unstructured":"Parra Sanchez AR, Voskuyl AE, van Vollenhoven RF. Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat Rev Rheumatol. 2022;18(3):146\u201357.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1508_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41584-019-0170-5","volume":"15","author":"R van Vollenhoven","year":"2019","unstructured":"van Vollenhoven R. Treat-to-target in rheumatoid arthritis\u2014are we there yet? Nat Rev Rheumatol. 2019;15(3):180\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"1508_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102398","volume":"110","author":"M Dougados","year":"2020","unstructured":"Dougados M. Treat to target in axial spondyloarthritis: from its concept to its implementation. J Autoimmun. 2020;110:102398.","journal-title":"J Autoimmun"},{"issue":"5","key":"1508_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103773","volume":"24","author":"M Piga","year":"2025","unstructured":"Piga M, Parodis I, Touma Z, et al. Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force. Autoimmun Rev. 2025;24(5):103773.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1508_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"1508_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.04411.x","volume":"26","author":"U Mrowietz","year":"2012","unstructured":"Mrowietz U. Implementing treatment goals for successful long-term management of psoriasis. J Eur Acad Dermatol Venereol. 2012;26(Suppl 2):12\u201320.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1508_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2310\/7750.2014.13151","volume":"19","author":"W Gulliver","year":"2015","unstructured":"Gulliver W, Lynde C, Dutz JP, et al. Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis. J Cutan Med Surg. 2015;19(1):22\u20137.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"1508_CR14","doi-asserted-by":"publisher","first-page":"adv00402","DOI":"10.2340\/00015555-3751","volume":"101","author":"M De Bruin-Weller","year":"2021","unstructured":"De Bruin-Weller M, Biedermann T, Bissonnette R, et al. Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies. Acta Derm Venereol. 2021;101(2):adv00402.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"1508_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jaad.2023.01.053","volume":"89","author":"J Yeung","year":"2023","unstructured":"Yeung J, Gooderham MJ, Hong HC, et al. Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: a Canadian perspective. J Am Acad Dermatol. 2023;89(2):372\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1508_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jaci.2017.04.015","volume":"140","author":"Y Han","year":"2017","unstructured":"Han Y, Chen Y, Liu X, et al. Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: a meta-analysis of randomized clinical trials. J Allergy Clin Immunol. 2017;140(3):888-91 e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1508_CR17","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/jdv.20229","volume":"38","author":"JI Silverberg","year":"2024","unstructured":"Silverberg JI, Gooderham M, Katoh N, et al. Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis. J Eur Acad Dermatol Venereol. 2024;38(11):2139\u201348.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1508_CR18","doi-asserted-by":"publisher","first-page":"adv18452","DOI":"10.2340\/actadv.v104.18452","volume":"104","author":"SG Kwatra","year":"2024","unstructured":"Kwatra SG, De Bruin-Weller M, Silverberg JI, et al. Targeted combined endpoint improvement in patient and disease domains in atopic dermatitis: a treat-to-target analysis of adults with moderate-to-severe atopic dermatitis treated with upadacitinib. Acta Derm Venereol. 2024;104:adv18452.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"1508_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40257-025-00923-1","volume":"26","author":"Z Tong","year":"2025","unstructured":"Tong Z, Zeng X, Huang F, et al. Upadacitinib dose reduction regimen in elderly patients with atopic dermatitis, guided by treat-to-target consensus recommendations. Am J Clin Dermatol. 2025;26(3):437\u201347.","journal-title":"Am J Clin Dermatol"},{"key":"1508_CR20","doi-asserted-by":"crossref","unstructured":"Valente C, Figueira Vilela B, Paiva-Lopes MJ, Duarte B. The efficacy of dupilumab largely exceeds the 6-month treat-to-target goals: an analysis in an atopic dermatitis referral center. Actas Dermosifiliogr. 2025;116(7):778\u201380.","DOI":"10.1016\/j.ad.2023.10.062"},{"issue":"11","key":"1508_CR21","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.jaip.2024.08.052","volume":"12","author":"A De Benedetto","year":"2024","unstructured":"De Benedetto A, Boguniewicz M, Ong PY, Chu DK, Schneider LC. Atopic Dermatitis (Eczema) Guidelines 2023: highlights. J Allergy Clin Immunol Pract. 2024;12(11):2955\u201365.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1508_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaad.2022.08.068","volume":"89","author":"R Sidbury","year":"2023","unstructured":"Sidbury R, Alikhan A, Bercovitch L, et al. Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):128\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1508_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/all.14631","volume":"76","author":"D Siegels","year":"2021","unstructured":"Siegels D, Heratizadeh A, Abraham S, et al. Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. Allergy. 2021;76(4):1053\u201376.","journal-title":"Allergy"},{"issue":"1","key":"1508_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jdv.19506","volume":"38","author":"Y Renert-Yuval","year":"2024","unstructured":"Renert-Yuval Y, Del Duca E, Arents B, et al. Treat-to-target in dermatology: a scoping review and International Eczema Council survey on the approach in atopic dermatitis. J Eur Acad Dermatol Venereol. 2024;38(1):42\u201351.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01508-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01508-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01508-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:07:26Z","timestamp":1758719246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01508-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1508"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01508-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Zhao Wang, Luyue Zhang, Ruitao Fan, Jing shi, Miao Qin, Shijiao Xu, Songmei Geng has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Reviewed and approved by the Second Affiliated Hospital of Xi\u2019an Jiao Tong University; approval (protocol code 2022265). The study was conducted in accordance with applicable regulations, guidelines, and the ethical principles of the Declaration of Helsinki. The patients in this manuscript have given written informed consent to the publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}